Percutaneous intervention

Toda K, Mackenzie K, Mehra MR, DiCorte CJ, Davis JE, McFadden PM, Ochsner JL, White C, Van Meter CH Jr . Revascularization in severe ventricular dysfunction (15% < OR = LVEF < OR = 30%) a comparison of bypass grafting and percutaneous intervention. Ann Thorac Surg. 2002 Dec 74(6) 2082-7. [Pg.84]

Konstam MA, Czerska B, Bohm M, Oren RM, Sadowski J, Khanal S, Abraham T, Wasler A, Dahm JB, Gavazzi A, Gradinac S, Legrand V, Mohacsi P, Poelzl G, Radovancevic B, Van Bakel AB, Zile MR, Cabuay B, Bartus K, Jansen P. Aortic flow augmentation a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. Circulation 2005 112 3107-3114. [Pg.92]

Stone GW, Mehran R, Dangas G, et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention, A device-specific analysis of 7174 patients. Circulation 2001 ... [Pg.56]

Marso SR Lincoff AM, Ellis SG, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus results of the EPISTENT (Evaluation of platelet llb/llla inhibitor for stenting trial) diabetic substudy. Circulation 1999 ... [Pg.58]

A frequently cited mechanism of action for these agents is phosphodiesterase (PDE) inhibition and the associated antiplatelet effects that accompany increases in intracellular cyclic adenosine monophosphate (cAMP). In fact, the effects of these drugs go far beyond their direct effect on PDE inhibition or platelet function. This chapter discusses (/) cyclic nucleotides, PDE, and PDE inhibitors (if) the mechanisms of action of dipyridamole and cilostazol (Hi) drug issues and (iv) current clinical applications for dipyridamole and cilostazol, including recent clinical trials that may have changed our perception of the possible utility of these agents for percutaneous intervention. [Pg.69]

Nikolsky E, Dangas GD. Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia. Semin Thromb Hemost 2004 30 305-3 14. [Pg.105]

Reports of high incidences of aspirin resistance may be due to laboratory measurements based on nonspecific methods that do not isolate the response of platelet COX-1 to aspirin or due to an inadequate dose required to fully inhibit the COX-1 in selected patients. Clopidogrel nonresponsiveness is a consistent phenomenon observed in research studies conducted at multiple medical centers around the world. Data from small studies support that patients with high ex vivo platelet reactivity to ADP during and after percutaneous intervention may be at greatest risk for subsequent ischemic events. [Pg.150]

Khanal S, Attallah N, Smith DE, et al, Statin therapy reduces contrast-induced nephropathy an analysis of contemporary percutaneous interventions, The potential role of statins in contrast nephropathy, Am J Med 2005 I I 8 843-849. [Pg.169]

Ribichini p Tomai p Ferrero V et al. Immunosuppresive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD Study. Eurointervention Journal 2005 1 173-1 80. [Pg.209]

Kao J, Tobis J, McClelland RL, et al. Investigators in the Prevention of Restenosis with Tranilast and its Outcomes Trial. Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention. Am J Cardiol 2004 93 1347-1350, A5. [Pg.481]

Rocha-Singh KJ, Rutherford J. Glycoprotein llb-llla receptor inhibition with eptifibatide in percutaneous intervention for symptomatic peripheral vascular disease the circulate pilot trial. Catheter Cardiovasc Interv 2005 66(4) 470-473. [Pg.581]

Shrma AK, Hamwi SM, Garg N, Castagna MT, Suddath W, Ellahham S, Lindsay J. Percutaneous intervention in patients with cocaine-associated myocardial infarction a case series and review. Catheter Cardiovasc Intervention 2002 56 346-52. [Pg.528]

There are no clear recommendations concerning indications for percutaneous interventional procedures. It is uncertain whether the metastases have been completely removed when guiding is based on imaging techniques. Moreover, the extent of the placed necrosis can only be assessed in a limited way however, evaluation is more exact if the resected tissue is analyzed histologically. [Pg.800]

Kereiakes DJ, Broderick TM, Whang DD, Anderson L, Eye D. Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention. Am J Cardiol 1997 80(5) 633-4. [Pg.7]

D. S. Baim, D. Wahr, B. George, M. B. Leon, J. Greenberg, D. E. Cutlip, U. Kaya, J. J. Popma, K. K. L. Ho and R. E. Kuntz, Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts, Circulation 105, 1285-1290 (2002). [Pg.143]

G. W. Stone, C. Rogers, J. Hermiller, R. Feldman, P. Hall, R. Haber, A. Masud, P. Cambier, R. P. Caputo, M. Turco, R. Kovach, B. Brodie, H. C. Herrmann, R. E. Kuntz, J. J. Popma, S. Ramec and D. A. Cox, Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts, Circulation 108, 548-553 (2003). [Pg.143]

DeGeare VS, Stone GW, Grines L, et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention a pooled analysis of the primary angioplasty in myocardial infarction trials. Am J Cardiol 2000 86 30-34. [Pg.109]

Keywords Coronary angiography, percutaneous intervention (PCI), coronary bypass surgery (CABG), Testenosis, acute myocardial infarction, insulin-glucose infusion. [Pg.187]

CABG coronary bypass surgery, PCI percutaneous intervention, STEMI ST-segment elevation myocardial infarction. [Pg.194]

Marso SP, Lincoff M, Elklis SG, Bhatt DL, Tanguay JF, Kleiman NS, Hammoud T, Booth JE, Sapp SK, Topol EJ. Optimizing the percutaneous interventional outcomes for patients with diabetes. Results from the Epistent Diabetic Substudy. Circulation 1999 100 2477-2484. [Pg.196]

Kowalski O, Lenarczyk R, Prokopczuk J et al (2006) Effects of percutaneous intervention within the coronary sinus on the success rate of implantations of resynchronization pacemakers. Pacing Clin Electrophysiol 29(10) 1075-1080... [Pg.114]

Schwerck W, Braun B, Dombrowsky H (1979) Real time ultrasound examination in the diagnosis of gastrointestinal tumours. J Clin Ultrasound 7 425-431 Sheafor DH, Paulson EK, Simmons CM et al (1998) Abdominal percutaneous interventional procedures comparison of CT and US guidance. Radiology 207 705-710 Shidham VB, Weiss JP, Quinn TJ et al (1998) Fine needle aspiration cytology of gastric solitary fibrous tumor. A case report. Acta Cytol 42 1159-1166 Smith EH (1984) The hazards of fine-needle aspiration biopsy. [Pg.219]

Walsh, C.J., Hanumara, N.C., Slocum, A.H., Shepard, J.A., Gupta, R. A patient-mounted, telerobotic tool for ct-guided percutaneous interventions. Journal of Medical Devices 2(1), 011007-10 (2008)... [Pg.483]

Loser, M.H., Navab, N. A new robotic system for visually controlled percutaneous interventions under ct fluoroscopy. In Medical Image Computing and Computer-Assisted Intervention (MICCAI), Pittsburgh, USA, pp. 887-896, October 11-14 2000... [Pg.484]

Chen, X. Instrument guide for MRI-guided percutaneous interventions. PhD Dissertation, Cambridge Massachusetts Institute of Technology (2010)... [Pg.484]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...